NCT01395277

Brief Summary

Groups of naturally occurring compounds called flavonoids are found in foods such as fruits and vegetables, red wine, tea, dark chocolate and cocoa products. Diets rich in flavonoids are associated with decreased risk for cardiovascular disease and major cardiovascular events (i.e. myocardial infarction) and have been shown to improve blood pressure, insulin sensitivity, and vascular function in a variety populations (Type II diabetes, elderly, smokers, etc.). The presumed beneficial effects of these compounds are thought to act through their inherent ability to scavenge free radicals. Specifically flavonoids scavenge superoxide anions which are free radicals that react with nitric oxide (NO) to produce peroxynitrite. The formation of peroxynitrite ultimately reduces the bioavailability of NO which is essential for vasodilation and thus vascular health and function. Normal aging is associated with impaired endothelial function, which presumably is due to less than optimal levels of NO bioavailability. Therefore, interventions that can increase NO bioavailability would be expected to improve microvascular function and vascular health in this population. The purpose of this study is to investigate the effects of dietary flavonoid supplementation on the vasodilatory capacity of the cutaneous vasculature, as well as on cerebral vascular reactivity and arterial stiffness in young and old humans. This study will test the hypothesis that acute dietary flavonoid treatment will improve impaired cutaneous vasodilatory capacity, cerebral vasomotor reactivity, and reduce arterial stiffness in older but not young humans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 15, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

August 10, 2015

Completed
Last Updated

August 10, 2015

Status Verified

July 1, 2015

Enrollment Period

2.7 years

First QC Date

July 13, 2011

Results QC Date

March 24, 2015

Last Update Submit

July 13, 2015

Conditions

Keywords

Nitric OxideVascular FunctionAgingBlood PressureArterial StiffnessCardiovascular DiseaseCerebral Blood Flow

Outcome Measures

Primary Outcomes (1)

  • Cutaneous Blood Flow Response to Local Heating of the Skin.

    Local heating of the cutaneous vasculature to 42 degree C is commonly used to evoke a maximal skin blood flow response (only at the site of local heating). This response is almost entirely dependent on nitric oxide mediated vasodilation.

    prior to (baseline) and 2 hours post beverage consumption

Secondary Outcomes (1)

  • Pulse Wave Velocity / Arterial Stiffness

    Prior to (baseline) and 2 hours following beverage consumption

Study Arms (2)

High Flavanol first then Low Flavanol

EXPERIMENTAL

The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "high" flavanol content and 2) before and 2 hours following consumption of a beverage with "low" flavanol content.

Dietary Supplement: High Flavanol first then Low Flavanol

Low Flavanol first then High Flavanol

EXPERIMENTAL

The measurements will be made on all study participants on two separate occasions; 1) before and 2 hours following consumption of a beverage with "low" flavanol content and 2) before and 2 hours following consumption of a beverage with "high" flavanol content.

Dietary Supplement: Low Flavanol first then High Flavanol

Interventions

The high flavanol trial will be performed following consumption of a beverage containing 1,050 mg of commercially available Cocoa Flavanols which will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption. The low flavanol trial will be performed following consumption of a beverage containing 0 mg of Cocoa Flavanols which will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.

Also known as: dark chocolate beverage
High Flavanol first then Low Flavanol

The low flavanol trial will be performed following consumption of a beverage containing 0 mg of Cocoa Flavanols which will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption. The high flavanol trial will be performed following consumption of a beverage containing 1,050 mg of commercially available Cocoa Flavanols which will be mixed into 250 ml of distilled water. The subjects will consume this beverage and measurements will be performed 2 hours after consumption.

Also known as: chocolate, Mars Incorporated
Low Flavanol first then High Flavanol

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and Females between 18 - 26 years old
  • Males and Females between 65 - 80 years old

You may not qualify if:

  • cardiovascular disease
  • metabolic disease
  • neurological disease
  • Pregnant lady
  • Current smoker (or regularly smoked within last year)
  • Currently taking medications known to effect the autonomic nervous system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Austin: Environmental and Autonomic Physiolgy Laboratory

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Interventions

Chocolate

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Results Point of Contact

Title
Dr. R. Matthew Brothers
Organization
University of Texas at Austin

Study Officials

  • R. Matthew Brothers, PhD

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 13, 2011

First Posted

July 15, 2011

Study Start

September 1, 2011

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

August 10, 2015

Results First Posted

August 10, 2015

Record last verified: 2015-07

Locations